ArticleOncology letters2019

Metformin selectively targets 4T1 tumorspheres and enhances the antitumor effects of doxorubicin by downregulating the AKT and STAT3 signaling pathways.

Yun-Suk Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.